A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P60
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Slingluff, Craig L
Petroni, Gina R
Olson, Walter C
Chianese-bullock, Kimberly A
Smith, Kelly T
Smolkin, Mark E
Galeassi, Nadedja
Grosh, William
Weiss, Geoffrey
Scott, Kristy
Hornillo, Ana
Article History
First Online: 6 November 2014